Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of UNI91103 intranasal spray
for treatment of coronavirus disease 2019 (COVID-19) in asymptomatic or mildly symptomatic
adults.